Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Hemosol (HML.TO)

Hemosol (HML.TO)

0.00
-0.00 (0.00%)
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Hemosol(HML.TO)

Jan 23, 2002
Have ahd difficulties in their trials. May have a weak cash position.
Photo of Mike WeirMike WeirUnlock Rating
$7.45

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
DON'T BUY

Hemosol(HML.TO)

Jan 09, 2002
Starting to move up, but prefers to wait for the product to start selling.
Photo of David DriscollDavid DriscollUnlock Rating
$9.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Dec 31, 2001
A long term situation, but expects it will do OK.
Photo of Malvin SpoonerMalvin SpoonerUnlock Rating
$7.35

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Dec 28, 2001
Sees it going up. Use a $6.90 stop loss. Expects it to get to $8.75 at which time it should be looked at again.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$7.49

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Hemosol(HML.TO)

Dec 21, 2001
A lot of competition in blood substitutes.
Photo of Robert FloydRobert FloydUnlock Rating
$7.40

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Dec 06, 2001
Prefers other companies that have earnings. Might buy at $3.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$5.90

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Nov 28, 2001
Wait for FDA approval.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$6.02

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Nov 27, 2001
If you own, hold.
Photo of John ZechnerJohn ZechnerUnlock Rating
$6.25

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
DON'T BUY

Hemosol(HML.TO)

Nov 26, 2001
Watch how the trials go.
Photo of Fred KetchenFred KetchenUnlock Rating
$6.40

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Hemosol(HML.TO)

Nov 22, 2001
Analysts are expecting a large upside. Will take time to get through the FDA phases.
Photo of Robert FloydRobert FloydUnlock Rating
$6.50

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Nov 05, 2001
Wait for FDA approval to go through. Will be a good product.
Photo of David DriscollDavid DriscollUnlock Rating
$4.80

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Oct 25, 2001
A worthwhile stock to own a little bit. At a good price.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$6.45

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Hemosol(HML.TO)

Oct 11, 2001
Good product. Phase 3is delayed for a year. Lots of competition, but room for all. Speculative.
Photo of Richard StoneRichard StoneUnlock Rating
$5.98

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Sep 07, 2001
Will take a while for the product to come on stream. Has strong competition.
Photo of Fred KetchenFred KetchenUnlock Rating
$4.47

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Sep 05, 2001
High valuation and delay on trials was a downer.
Photo of Ian NakamotoIan NakamotoUnlock Rating
$4.70

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 31 to 45 of 78 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica